STOLETNIK-FARMA, OOO, Moscow

Accounting reports

Previously

Name	STOLETNIK-FARMA, OOO
INN	7703734671
KPP	502901001
OGRN	5107746048416
OKPO	69649369
Address	141009, Moskovskaya Oblast', g. Mytischi, ul. Kolontsova, d. D. 5, of. POMESCH. 805A

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract

Download an extract from EGRUL

We guarantee to provide you with an actual
information extract

OKVED code	Type	Name of activity type
Data on types of economic activities STOLETNIK-FARMA, OOO according to EGRUL
47.73	Core activity	Retailing drugs in specialized stores (pharmacies)
21.1	Additional activity	Pharmaceutical substances
21.20.1	Additional activity	Production of drugs
All types of activities
32.5	Additional activity	Manufacture of medical instruments and equipment
46.1	Additional activity	Commercial mediation of all kinds
46.18.1	Additional activity	Agents specialized in the wholesale trade of pharmaceutical products, products used for medical purposes, perfume and cosmetics, including soap and detergents
46.46	Additional activity	Wholesale of pharmaceutical goods
47.74	Additional activity	Retailing products used for medical purposes, orthopedic goods in specialized stores
47.75	Additional activity	Retailing of cosmetics and personal hygiene products in specialized stores
86.21	Additional activity	General practice

Registration information

Registration date	22.12.2010
Registering department	Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby 46 po g. Moskve

Description

STOLETNIK-FARMA, OOO (Moscow; INN 7703734671) was registered on 22 Dec 2010. The company's authorized capital as of July 1, 2012 was 40000 rub.

Type of ownership of STOLETNIK-FARMA, OOO - Limited liability companies.

Form of ownership of STOLETNIK-FARMA, OOO - Private property.

Principal activities of STOLETNIK-FARMA, OOO: retailing drugs in specialized stores (pharmacies) (47.73), pharmaceutical substances (21.1), production of drugs (21.20.1).

Industry

Economic indicators

2021

Net profit (RAS) of STOLETNIK-FARMA, OOO dropped in 2021 2.76 times to 4.69 million RUB from 12.92 million RUB over the same period in 2020, the company informed.

Revenue decreased in the accounting period by 30.23% to 209.10 million RUB from 299.72 million RUB in 2020; cost of goods sold decreased by 27.85% to 177.20 million RUB from 245.61 million RUB; sales profit fell 31.64 times to 514.00 thousand RUB from 16.26 million RUB.

2020

Net profit (RAS) of STOLETNIK-FARMA, OOO grew over 2020 1.92 times to 12.92 million RUB from 6.73 million RUB over 2019, the company informed.

Revenue decreased in the accounting period by 5.33% to 299.72 million RUB from 316.61 million RUB in 2019; cost of goods sold remained at the same level amounting to 245.61 million RUB compared to 246.55 million RUB; sales profit went up 1.82 times to 16.26 million RUB from 8.92 million RUB.

2019

Net profit (RAS) of STOLETNIK-FARMA, OOO grew over 2019 by 12.63% to 6.73 million RUB from 5.97 million RUB over 2018, the company informed.

Revenue increased in the accounting period by 8.47% to 316.61 million RUB from 291.88 million RUB over 2018; cost of goods sold grew by 9.31% to 246.55 million RUB from 225.54 million RUB; sales profit went up by 31.17% to 8.92 million RUB from 6.80 million RUB.

2018

Net profit (RAS) of STOLETNIK-FARMA, OOO made up 5.97 million RUB over 2018 compared to net loss of 36.36 million RUB over 2017, the company informed.

Revenue decreased in the accounting period by 27.86% to 291.88 million RUB from 404.58 million RUB in 2017; cost of goods sold decreased by 35.52% to 225.54 million RUB from 349.76 million RUB; sales profit made up 6.80 million RUB compared to sales loss of 29.64 million RUB.

2017

Net loss (RA) of STOLETNIK-FARMA, OOO made up 36.36 million RUB over 2017 compared to net profit of 24.14 million RUB over 2016, the company informed.

Revenue increased in the accounting period by 6.10% to 404.58 million RUB from 381.31 million RUB over 2016; cost of goods sold grew by 10.14% to 349.76 million RUB from 317.56 million RUB; sales loss made up 29.64 million RUB compared to sales profit of 28.52 million RUB.

Financial Highlights

Revenue and earnings data

Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Pay online

Companies in the region

Guarantees

We guarantee

provision of
relevant
information

Payment methods

Statistics

Companies

12 161 930

Reports

17 430 886

Rrocessed requests

Extract from EGRUL:

Today, 12:41 PM

Accounting reports: